Skip to main content
logo
PharmX Technologies Limited (ASX:PHX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1000
0.00 (0.00%)
Jul 29, 2026, 9:59 AM AEST

PharmX Technologies Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
7.657.538.096.135.3911.88
Revenue Growth
1.55%-6.97%32.10%13.78%-54.65%11.58%
Gross Profit
1.732.133.962.012.143.38
Operating Income
-0.710.110.24-0.670.131.22
Net Income
-0.93-0.26-1.77-1.050.251.09
Earnings Per Share
-0.00-0.00-0.00-0.000.000.00
EPS Growth
-----78.89%300.60%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
3.214.1713.1412.815.766.48
Total Debt
0.720.890.240.030.330.32
Net Cash (Debt)
2.493.2812.912.775.436.16
Net Cash Growth
-23.95%-74.58%0.95%135.12%-11.76%287.23%
Net Cash Per Share
0.000.010.020.020.010.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
1.01-8.133.2110.943.283.16
Capital Expenditures
-0.03-0.03-0.02-0.09-0.1-0.3
Free Cash Flow
0.98-8.163.1910.863.192.86
Free Cash Flow Growth
---70.63%240.94%11.29%1243.66%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
22.66%28.23%48.98%32.72%39.74%28.44%
Operating Margin
-9.30%1.46%3.02%-10.85%2.36%10.28%
Pretax Margin
-9.73%1.05%2.48%-11.73%2.27%11.33%
Profit Margin
-12.17%-3.51%-21.86%-17.15%4.68%9.19%
FCF Margin
12.79%-108.38%39.40%177.23%59.15%24.10%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PE Ratio
----80.5247.59
Forward PE
-21.2521.2521.2521.2521.75
P/FCF Ratio
67.43-7.132.046.3718.14
PS Ratio
8.627.392.813.613.774.37